Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alice Mariottini

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
European Journal of Neurology|July 24, 2023
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantationAlice Mariottini, Antonio Lotti, Chiara Innocenti, et al.
European Journal of Neurology|April 7, 2022
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experienceAntonio Farina, Silvia Falso, Sara Cornacchini, et al.
European Journal of Neurology|August 6, 2024
Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic reviewBente Braun, Felix Fischbach, Lena Kristina Pfeffer, et al.
Frontiers in Immunology|December 10, 2024
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case seriesAlice Mariottini, Riccardo Boncompagni, Diletta Cozzi, et al.
Multiple Sclerosis and Related Disorders|March 8, 2023
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experienceAndrea Bertozzi, Alice Mariottini, Leonardo Marchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2020
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosisAlice Mariottini, Stefano Filippini, Chiara Innocenti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 26, 2024
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosisAlice Mariottini, Chiara Nozzoli, Ilaria Carli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2020
Prevalence of disability improvement as a potential outcome for multiple sclerosis trialsAlessio Signori, Giacomo Boffa, Francesca Bovis, et al.
Frontiers in Immunology|April 25, 2020
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive TherapiesRoberta Amoriello, Victor Greiff, Alessandra Aldinucci, et al.
European Journal of Neurology|February 11, 2022
Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosisAlice Mariottini, Giovanni Bulgarini, Benedetta Forci, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
European Journal of Neurology|July 24, 2023
Effect of the COVID-19 pandemic on disease activity in multiple sclerosis patients treated with hematopoietic stem cell transplantationAlice Mariottini, Antonio Lotti, Chiara Innocenti, et al.
European Journal of Neurology|April 7, 2022
Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experienceAntonio Farina, Silvia Falso, Sara Cornacchini, et al.
European Journal of Neurology|August 6, 2024
Exploring the therapeutic potential of autologous hematopoietic stem cell transplantation in progressive multiple sclerosis-a systematic reviewBente Braun, Felix Fischbach, Lena Kristina Pfeffer, et al.
Frontiers in Immunology|December 10, 2024
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case seriesAlice Mariottini, Riccardo Boncompagni, Diletta Cozzi, et al.
Multiple Sclerosis and Related Disorders|March 8, 2023
Safety and effectiveness of the booster dose of mRNA COVID-19 vaccines in people with multiple sclerosis: A monocentric experienceAndrea Bertozzi, Alice Mariottini, Leonardo Marchi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2020
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosisAlice Mariottini, Stefano Filippini, Chiara Innocenti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 26, 2024
Cost and effectiveness of autologous haematopoietic stem cell transplantation and high-efficacy disease-modifying therapies in relapsing-remitting multiple sclerosisAlice Mariottini, Chiara Nozzoli, Ilaria Carli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2020
Prevalence of disability improvement as a potential outcome for multiple sclerosis trialsAlessio Signori, Giacomo Boffa, Francesca Bovis, et al.
Frontiers in Immunology|April 25, 2020
The TCR Repertoire Reconstitution in Multiple Sclerosis: Comparing One-Shot and Continuous Immunosuppressive TherapiesRoberta Amoriello, Victor Greiff, Alessandra Aldinucci, et al.
European Journal of Neurology|February 11, 2022
Autologous haematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosisAlice Mariottini, Giovanni Bulgarini, Benedetta Forci, et al.
Pageof 5